UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review

PloS one, 2011-11, Vol.6 (11), p.e26646

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

PloS one, 2011-11, Vol.6 (11), p.e26646-e26646

2011

Link zum Volltext

Verfügbarkeit prüfen

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

PloS one, 2009-11, Vol.4 (11), p.e7835

2009

Link zum Volltext

Verfügbarkeit prüfen

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-01, Vol.79 (1), p.20-26

2013

Link zum Volltext

Verfügbarkeit prüfen

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2008-03, Vol.59 (3), p.377-384

2008

Link zum Volltext

Verfügbarkeit prüfen

Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades

PloS one, 2012-08, Vol.7 (8), p.e42798

2012

Link zum Volltext

Verfügbarkeit prüfen

Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP‐C promoter

Cancer science, 2008-09, Vol.99 (9), p.1747-1753

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of HER2 Gene and Protein Status on the Treatment Outcome of Cisplatin-Based Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-05, Vol.3 (5), p.477-482

2008

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma

Cancer science, 2008-02, Vol.99 (2), p.303-308

2008

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3952-3957

2007

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications

Journal of cancer research and clinical oncology, 2009-08, Vol.135 (8), p.1055-1059

2009

Link zum Volltext

Verfügbarkeit prüfen

Response to Galán-Puchades and Fuentes

The American journal of gastroenterology, 2019-02, Vol.114 (2), p.357-357

2019

Link zum Volltext

Verfügbarkeit prüfen

Response to Galán-Puchades and Fuentes

The American journal of gastroenterology, 2019-01, p.1

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of Early Serial Change in Serum Carcinoembryonic Antigen Levels as a Predictive Marker for Radiological Response to Gefitinib in Japanese Patients with Non-small Cell Lung Cancer

Anticancer research, 2007-05, Vol.27 (3B), p.1737-1742

2007

Link zum Volltext

Verfügbarkeit prüfen

Taenia saginata Infection Diagnosed Based on the Number of Uterine Branches Observed During Capsule Endoscopy

The American journal of gastroenterology, 2018-03, Vol.113 (3), p.327-327

2018

Link zum Volltext

Verfügbarkeit prüfen

Bi-Stable Vibration Power Generation System Using Electromagnetic Motor and Efficiency Improvement by Stochastic Resonance

American journal of engineering and applied sciences, 2023-03, Vol.16 (3), p.76-91

2023

Link zum Volltext

Verfügbarkeit prüfen

Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer

Acta medica Okayama, 2010-02, Vol.64 (1), p.33-37

2010

Link zum Volltext

Verfügbarkeit prüfen

The impact of epidermal growth factor receptor gene status on gefitinib‐treated Japanese patients with non‐small‐cell lung cancer

International journal of cancer, 2007-03, Vol.120 (6), p.1239-1247

2007

Link zum Volltext

Verfügbarkeit prüfen

Relationship between Response and Survival in More Than 50,000 Patients with Advanced Non-small Cell Lung Cancer Treated with Systemic Chemotherapy in 143 Phase III Trials

Journal of thoracic oncology, 2007-05, Vol.2 (5), p.402-407

2007

Link zum Volltext

Verfügbarkeit prüfen

Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2009-03, Vol.4 (3), p.311-317

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

Journal of thoracic oncology, 2007-07, Vol.2 (7), p.632-637

2007

Link zum Volltext

Verfügbarkeit prüfen

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first‐line, systemic chemotherapy

Cancer, 2007-03, Vol.109 (5), p.939-948

2007

Link zum Volltext

Verfügbarkeit prüfen

Prospective cohort study of serum sialylated glycoprotein (KL-6) as a prognostic marker in patients (pts) with non-small cell lung cancer (NSCLC) receiving gefitinib monotherapy: Okayama Lung Cancer Study Group 0703

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e19023-e19023

2013

Link zum Volltext

Verfügbarkeit prüfen

Survival post-progression (SPP) in phase III trials of chemotherapy in advanced NSCLC: Its potentially different impact on OS in the first-line and salvage settings

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18027-e18027

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of S-1 and concurrent thoracic radiotherapy (TRT) for elderly pts with locally advanced non-small cell lung cancer (LA-NSCLC): Okayama Lung Cancer Study Group trial 0801

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7576-7576

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Englisch
(171)
Japanisch
(95)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(87)
Humans
(85)
Male
(64)
Female
(61)
Aged
(39)
Middle Aged
(38)
Oncology
(37)
Adult
(29)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Lung Neoplasms - Drug Therapy
(26)
Tumors
(24)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(21)
Physical Sciences
(16)
Pneumology
(16)
Retrospective Studies
(16)
Treatment Outcome
(16)
Tumors Of The Respiratory System And Mediastinum
(16)
Animals
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer

Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades

Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP‐C promoter

Impact of HER2 Gene and Protein Status on the Treatment Outcome of Cisplatin-Based Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications

Response to Galán-Puchades and Fuentes

Response to Galán-Puchades and Fuentes

Role of Early Serial Change in Serum Carcinoembryonic Antigen Levels as a Predictive Marker for Radiological Response to Gefitinib in Japanese Patients with Non-small Cell Lung Cancer

Taenia saginata Infection Diagnosed Based on the Number of Uterine Branches Observed During Capsule Endoscopy

Bi-Stable Vibration Power Generation System Using Electromagnetic Motor and Efficiency Improvement by Stochastic Resonance

Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer

The impact of epidermal growth factor receptor gene status on gefitinib‐treated Japanese patients with non‐small‐cell lung cancer

Relationship between Response and Survival in More Than 50,000 Patients with Advanced Non-small Cell Lung Cancer Treated with Systemic Chemotherapy in 143 Phase III Trials

Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer

Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first‐line, systemic chemotherapy

Prospective cohort study of serum sialylated glycoprotein (KL-6) as a prognostic marker in patients (pts) with non-small cell lung cancer (NSCLC) receiving gefitinib monotherapy: Okayama Lung Cancer Study Group 0703

Survival post-progression (SPP) in phase III trials of chemotherapy in advanced NSCLC: Its potentially different impact on OS in the first-line and salvage settings

A phase II study of S-1 and concurrent thoracic radiotherapy (TRT) for elderly pts with locally advanced non-small cell lung cancer (LA-NSCLC): Okayama Lung Cancer Study Group trial 0801

Suchergebnisse filtern